Role of Integrin, FAK (Focal Adhesion Kinase) and ERK (Extracellular Signal Regulated Kinase) on the Suppressed Cell Proliferation of Endometrial Cancer Cells by GnRH (Gonadotropin-Releasing Hormone) |
Choi, Jong Rak
(Department of Clinical Pathology, Yonsei University)
Park, Dong Wook (Department of Molecular Science and Technology, Ajou University) Choi, Dong Soon (Department of Molecular Science and Technology, Ajou University) Min, Churl K. (Department of Molecular Science and Technology, Ajou University) |
1 | Grimbizis G, Tsalikis T, Tzioufa V, Kasapis M, Mantalenakis S. Regression of endometrial hyperplasia after treatment with the gonadotrophin-releasing hormone analogue triptorelin: a prospective study. Hum Reprod 1999; 14(2): 479-84 DOI ScienceOn |
2 | Limonta P, Moretti RM, Marelli MM, Motta M. The biology of gonadotropin hormone-releasing hormone: role in the control of tumor growth and progression in humans. Front Neuroendocrinol 2003; 24(4): 279 -95 DOI ScienceOn |
3 | Schally A. Luteinizing hormone-releasing hormone analogs: their impact on the control of tumorigenesis. Peptides 1999; 20(10): 1247-62 DOI ScienceOn |
4 | Meresman GF, Bilotas M, Buquet RA, Baranao RI, Sueldo C, Tesone M. Gonadotropin-releasing hormone agonist induces apoptosis and reduces cell proliferation in eutopic endometrial cultures from women with endometriosis. Fertil Steril 2003; 80(2): 702-7 DOI |
5 | Noci I, Borri P, Bonfirraro G, Chieffi O, Arcangeli A, Cherubini A, et al. Longstanding survival without cancer progression in a patient affected by endometrial carcinoma treated primarily with leuprolide. Br J Cancer 2001; 85: 333-6 DOI ScienceOn |
6 | Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat Rev Cancer 2002; 2: 91-100 DOI ScienceOn |
7 | Pereira JJ, Meyer T, Docherty SE, Reid HH, Marshall J, Thompson EW, et al. Bimolecular interaction of insulin-like growth factor (IGF) binding protein-2 with alphavbeta3 negatively modulates IGF-I-mediated migration and tumor growth. Cancer Res 2004; 64(3): 977-84 DOI ScienceOn |
8 | Stupack DG, Cheresh DA. Get a ligand, get a life: integrins, signaling and cell survival. J Cell Sci 2002; 115(Pt 19): 3729-38 DOI |
9 | Hordijk PL, Verlaan I, van Corven EJ, Moolenaar WH. Protein tyrosine phosphorylation induced by lysophosphatidic acid in Rat-1 fibroblasts. Evidence that phosphorylation of map kinase is mediated by the Gi-p21ras pathway. J Biol Chem 1994; 269(1): 645-51 |
10 | Levi NL, Hanoch T, Benard O, Rozenblat M, Harris D, Reiss N, et al. Stimulation of Jun N-terminal kinase (JNK) by gonadotropin-releasing hormone in pituitary alpha T3-1 cell line is mediated by protein kinase C, c-Src, and CDC42. Mol Endocrinol 1998; 12(6): 815-24 DOI ScienceOn |
11 | Borsig L, Wong R, Feramisco J, Nadeau DR, Varki NM, Varki A. Heparin and cancer revisited: mech-anistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci U S A 2001; 98(6): 3352-7 |
12 | Davidson L, Pawson AJ, Millar RP, Maudsley S. Cytoskeletal reorganization dependence of signaling by the gonadotropin-releasing hormone receptor. J Biol Chem 2004; 279: 1980-93 DOI ScienceOn |
13 | Subauste MC, Pertz O, Adamson ED, Turner CE, Junger S, Hahn KM. Vmculin modulation of paxillinFAK interactions regulates ERK to control survival and motility. J Cell Biol 2004; 165(3): 371-81 DOI ScienceOn |
14 | Savino L, Baldini B, Susini T, Pulli F, Antignani L, Massi GB. GnRH analogs in gynecological oncology: a review. J Chemother 1992; 4(5): 312-20 DOI |
15 | Wierman ME, Bruder JM, Kepa JK. Regulation of gonadotropin-releasing hormone (GnRH) gene expression in hypothalamic neuronal cells. Cell Mol Neurobiol 1995; 15(1): 79-88 DOI ScienceOn |
16 | Clayton RN, Catt KJ. Gonadotropin-releasing hormone receptors: characterization, physiological regulation, and relationship to reproductive function. Endocr Rev. 1981; 2(2): 186-209 DOI ScienceOn |
17 | Seger R, Krebs EG. The MAPK signaling cascade. FASEB J 1995; 9(9): 726-35 DOI |
18 | Del Pozo MA, Kiosses WB, Alderson NB, Meller N, Hahn KM, Schwartz MA. Integrins regulate GTPRae localized effector interactions through dissociation of Rho-GDI. Nat Cell Biol 2002; 4(3): 232-9 DOI ScienceOn |
19 | Takeuchi H, Kobori H, Kikuchi I, Sato Y, Mitsuhashi N. A prospective randomized study comparing endocrinological and clinical effects of two types of GnRH agonists in cases of uterine leiomyomas or endometriosis. J Obstet Gynaecol Res 2000; 26(5): 325-31 DOI ScienceOn |
20 | Huirne JA, Lambalk CB. Gonadotropin-releasinghormone-receptor antagonists. Lancet 2001; 358 (9295): 1793-803 DOI ScienceOn |
21 | Neill JD. GnRH and GnRH receptor genes in the human genome. Endocrinology 2002; 143(3): 737 -43 DOI ScienceOn |
22 | Luo X, Xu J, Chegini N. Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells. Reprod Biol Endocrinol 2003; 16: 125 |
23 | Wierman ME, Bruder JM, Kepa JK. Regulation of gonadotropin-releasing hormone (GnRH) gene expression in hypothalamic neuronal cells. Cell Mol Neurobiol 1996; 15(1): 79-88 DOI |
24 | Schally A, Nagy A. Targeted cytotoxic analogs of luteinizing hormone-releasing hormone: a reply. Eur J Endocrinol 2001; 144(5): 559 DOI ScienceOn |
25 | Santen RJ. Clinical review 37: Endocrine treatment of prostate cancer. J Clin Endocrinol Metab 1992; 75(3): 685-9 DOI |
26 | Kraus S, Naor Z, Seger R. Intracellular signaling path-ways mediated by the gonadotropin-releasing hormone (GnRH) receptor. Arch Med Res 2001; 32(6): 499-509 DOI ScienceOn |
27 | Kim WH, Lee BL, Jun SH, Song SY, Kleinman HK. Expression of 32/67 -kDa laminin receptor in laminin adhesion-selected human colon cancer cell lines. Br J Cancer 1998; 77(1): 15-20 |
28 | Lessey BA, Castelbaum AJ, Buck CA, Lei Y, Yowell CW, Sun J. Further characterization of endometrial integrins during the menstrual cycle and in pregnancy. Fertil Steril 1994; 62(3): 497-50 DOI |
29 | Kim KY, Choi KC, Park SH, Auersperg N, Leung PC. Extracellular signal-regulated protein kinase, but not c-Jun N-terminal kinase, is activated by type II gonadotropin-releasing hormone involved in the inhibition of ovarian cancer cell proliferation. J Clin Endocrinol Metab 2005; 90: 1670-7 DOI ScienceOn |
30 | Lessey BA, Damjanovich L, Coutifaris C, Castelbaum A, Albelda SM, Buck CA. Integrin adhesion molecules in the human endometrium. Correlation with the normal and abnormal menstrual cycle. J Clin Invest 1992; 90(1): 188-95 DOI |
31 | Emons G, Schroder B, Ortmann O, Westphalen S, Schulz KD, Schally AV. High affinity binding and direct antiproliferative effects of luteinizing hormonereleasing hormone analogs in human endometrial cancer cell lines. J Clin Endocrinol Metab 1993; 77: 1458-64 DOI ScienceOn |
32 | Luttrell LM, Daaka Y, Della Rocca GJ, Lefkowitz RJ. G protein-coupled receptors mediate two functionally distinct pathways of tyrosine phosphorylation in rat la fibroblasts. She phosphorylation and receptor endocytosis correlate with activation of Erk kinases. J Biol Chem 1997; 272(50): 31648-56 DOI ScienceOn |
33 | Kanamori M, Vanden Berg SR, Bergers G, Berger MS, Pieper RO. Integrin beta3 overexpression suppresses tumor growth in a human model of gliomagenesis: implications for the role of beta3 overexpression in glioblastoma multi forme. Cancer Res 2004; 64(8): 2751-8 DOI ScienceOn |
34 | Borsig L, Wong R, Hynes RO, Varki NM, Varki A. Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc Nati Acad Sci U S A 2002; 99(4): 2193-8 |
35 | Clayton RN, Catt KJ. Gonadotropin-releasing hormone receptors: characterization, physiological regulation, and relationship to reproductive function. Endocr Rev 1981; 2(2): 186-209 DOI ScienceOn |